Evidence map›Paper›PMID 32905230›Full record

ArticleToxicology research2020

Response to and recovery from treatment in human liver-mimetic clinostat spheroids: a model for assessing repeated-dose drug toxicity.

Stephen J Fey, Barbara Korzeniowska, Krzysztof Wrzesinski

Open access · hybridAbstract read
In one paragraph

Article in Toxicology research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. MatriGridBioengineering (Basel, Switzerland) · 2022
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephen J FeyCelVivo ApS, Middelfartvej 469, DK-5491 Blommenslyst, Denmark.ORCID 0000-0001-6463-9477
Barbara KorzeniowskaCelVivo ApS, Middelfartvej 469, DK-5491 Blommenslyst, Denmark.ORCID 0000-0001-6856-6703
Krzysztof WrzesinskiCelVivo ApS, Middelfartvej 469, DK-5491 Blommenslyst, Denmark.ORCID 0000-0002-0381-4523

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicines are usually prescribed for repeated use over shorter or longer times. Unfortunately, repeated-dose animal toxicity studies do not correlate well with observations in man. As emphasized by the '3Rs' and the desire to phase-out animal research,

Indexed as

3D cell cultureacetaminophenamiodaroneclinostatdiclofenacdrug toxicityHepG2–C3Ametforminphenforminrecovery from treatmentrepeated-dosevalproic acid

Identifiers

PMID32905230
PMCPMC7467243
OpenAlexW3035454867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.